Literature DB >> 25542861

Accelerated tumor progression in mice lacking the ATP receptor P2X7.

Elena Adinolfi1, Marina Capece1, Alessia Franceschini1, Simonetta Falzoni1, Anna L Giuliani1, Alessandra Rotondo2, Alba C Sarti1, Massimo Bonora1, Susanne Syberg3, Domenica Corigliano4, Paolo Pinton1, Niklas R Jorgensen3, Luigi Abelli5, Laura Emionite6, Lizzia Raffaghello7, Vito Pistoia7, Francesco Di Virgilio8.   

Abstract

The ATP receptor P2X7 (P2X7R or P2RX7) has a key role in inflammation and immunity, but its possible roles in cancer are not firmly established. In the present study, we investigated the effect of host genetic deletion of P2X7R in the mouse on the growth of B16 melanoma or CT26 colon carcinoma cells. Tumor size and metastatic dissemination were assessed by in vivo calliper and luciferase luminescence emission measurements along with postmortem examination. In P2X7R-deficient mice, tumor growth and metastatic spreading were accelerated strongly, compared with wild-type (wt) mice. Intratumoral IL-1β and VEGF release were drastically reduced, and inflammatory cell infiltration was abrogated nearly completely. Similarly, tumor growth was also greatly accelerated in wt chimeric mice implanted with P2X7R-deficient bone marrow cells, defining hematopoietic cells as a sufficient site of P2X7R action. Finally, dendritic cells from P2X7R-deficient mice were unresponsive to stimulation with tumor cells, and chemotaxis of P2X7R-less cells was impaired. Overall, our results showed that host P2X7R expression was critical to support an antitumor immune response, and to restrict tumor growth and metastatic diffusion. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25542861     DOI: 10.1158/0008-5472.CAN-14-1259

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

Review 1.  Expression and function of P2 receptors in hematopoietic stem and progenitor cells.

Authors:  Wenli Feng; Lina Wang; Guoguang Zheng
Journal:  Stem Cell Investig       Date:  2015-07-30

2.  P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.

Authors:  Hui Pan; Hongyan Ni; LeiLei Zhang; Yue Xing; Jiayan Fan; Peng Li; Tianyuan Li; Renbing Jia; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Tumour Biol       Date:  2016-07-28

Review 3.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

Review 4.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 5.  The P2X7 Receptor in the Maintenance of Cancer Stem Cells, Chemoresistance and Metastasis.

Authors:  Vanessa Fernandes Arnaud-Sampaio; Izadora Lorrany Alves Rabelo; Henning Ulrich; Claudiana Lameu
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

6.  P2RX7: A receptor with a split personality in inflammation and cancer.

Authors:  Francesco Di Virgilio
Journal:  Mol Cell Oncol       Date:  2015-02-03

7.  P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation.

Authors:  Zhequan Fu; Qingyu Lin; Bingxin Hu; Yingying Zhang; Weijia Chen; Jing Zhu; Yanzhao Zhao; Hak Soo Choi; Hongcheng Shi; Dengfeng Cheng
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

Review 8.  The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Authors:  Bertrand Allard; Maria Serena Longhi; Simon C Robson; John Stagg
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

9.  P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors.

Authors:  Andrea Romagnani; Elsa Rottoli; Emilia Maria Cristina Mazza; Tanja Rezzonico-Jost; Benedetta De Ponte Conti; Michele Proietti; Michela Perotti; Elisa Civanelli; Lisa Perruzza; Alberico L Catapano; Andrea Baragetti; Elena Tenedini; Enrico Tagliafico; Simonetta Falzoni; Francesco Di Virgilio; Giuseppe Danilo Norata; Silvio Bicciato; Fabio Grassi
Journal:  Cancer Res       Date:  2020-07-22       Impact factor: 12.701

10.  Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.

Authors:  Madiha Khalid; Sobia Manzoor; Hassam Ahmad; Arun Asif; Tariq Ali Bangash; Amer Latif; Shahla Jaleel
Journal:  Mol Biol Rep       Date:  2018-10-20       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.